INCY vs SRTAW · P/E 14, rev $5.14B vs rev $248.7M
Incyte Corporation (INCY) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. SRTAW currently screens at market cap $0.
Not investment advice. Open the INCY and SRTAW stock pages for the full models.
Not investment advice.